However, hormone therapy with ERa as the main body makes tumors prone to develop therapeutic drug resistance, more than 9 million breast cancer survivors worldwide suffer from menopausal estrogen consumption‐related symptoms and the side effects of cancer treatment.283. Here, ESR1 is linked to breast carcinoma.